Area under the serum glucose concentration profile during 24 hours after 4 weeks of treatment [clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac]

Area under the serum glucose concentration profile during 24 hours after 4 weeks of treatment [clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac]

Clinical Trials at Novo Nordisk
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes [clinicaltrials:NCT00612599]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Area under the serum glucose concentration profile during 24 hours after 4 weeks of treatment [clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac]

Clinical Trials at Novo Nordisk
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac
Bio2RDF identifier
b3b2a277db9c6cfc578a39b9ceb605ac
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac
measure [clinicaltrials_vocabulary:measure]
Area under the serum glucose concentration profile during 24 hours
time frame [clinicaltrials_vocabulary:time-frame]
after 4 weeks of treatment
description
Clinical Trials at Novo Nordisk
identifier
clinicaltrials_resource:b3b2a277db9c6cfc578a39b9ceb605ac
title
Area under the serum glucose c ...... urs after 4 weeks of treatment
@en
inDataset
type
label
Area under the serum glucose c ...... 2a277db9c6cfc578a39b9ceb605ac]
@en